All Stories

  1. The diagnostic value of nasal microbiota and clinical parameters in a multi-parametric prediction model to differentiate bacterial versus viral infections in lower respiratory tract infections

    Article • PLoS ONE, April 2022, PLOS

    J HAYS

  2. Therapeutic Efficacy of Novel Antimicrobial Peptide AA139-Nanomedicines in a Multidrug-Resistant Klebsiella pneumoniae Pneumonia-Septicemia Model in Rats

    Article • Antimicrobial Agents and Chemotherapy, June 2020, ASM Journals

    J HAYS

  3. Lessons learnt from the introduction of nanopore sequencing?

    Article • Clinical Microbiology and Infection, June 2020, Elsevier

    J HAYS

  4. Comment on: “A Multinational European Study of Patient Preferences for Novel Diagnostics to Manage Antimicrobial Resistance”

    Article • Applied Health Economics and Health Policy, March 2020, Springer Science + Business Media

    J HAYS

  5. Successful High-Dosage Monotherapy of Tigecycline in a Multidrug-Resistant Klebsiella pneumoniae Pneumonia–Septicemia Model in Rats

    Article • Antibiotics, March 2020, MDPI AG

    J HAYS

  6. Diversity, compositional and functional differences between gut microbiota of children and adults

    Article • Scientific Reports, January 2020, Springer Science + Business Media

    J HAYS

  7. Antimicrobial activity of two novel antimicrobial peptides AA139 and SET-M33 against clinically and genotypically diverse Klebsiella pneumoniae isolates with differing antibiotic resistance profiles

    Article • International Journal of Antimicrobial Agents, August 2019, Elsevier

    J HAYS

  8. Differences in Systemic IgA Reactivity and Circulating Th Subsets in Healthy Volunteers With Specific Microbiota Enterotypes

    Article • Frontiers in Immunology, March 2019, Frontiers

    J HAYS

  9. Understanding and overcoming the pitfalls and biases of next-generation sequencing (NGS) methods for use in the routine clinical microbiological diagnostic laboratory

    Article • European Journal of Clinical Microbiology & Infectious Diseases, March 2019, Springer Science + Business Media

    J HAYS

  10. The successful uptake and sustainability of rapid infectious disease and antimicrobial resistance point-of-care testing requires a complex ‘mix-and-match’ implementation package

    Article • European Journal of Clinical Microbiology & Infectious Diseases, February 2019, Springer Science + Business Media

    J HAYS

  11. Antibiotic misuse in respiratory tract infections in children and adults—a prospective, multicentre study (TAILORED Treatment)

    Article • European Journal of Clinical Microbiology & Infectious Diseases, February 2019, Springer Science + Business Media

    J HAYS

  12. Whole genome sequence analysis of NDM-1, CMY-4, and SHV-12 coproducing Salmonella enterica serovar Typhimurium isolated from a case of fatal burn wound infection

    Article • Infection and Drug Resistance, November 2018, Dove Medical Press

    Dr Padma Krishnan, J HAYS, Godfred Menezes

  13. Antibiotic-nanomedicines: facing the challenge of effective treatment of antibiotic-resistant respiratory tract infections

    Article • Future Microbiology, November 2018, Future Medicine

    J HAYS

  14. Developmental roadmap for antimicrobial susceptibility testing systems

    Article • Nature Reviews Microbiology, October 2018, Springer Science + Business Media

    J HAYS

  15. Monitoring of microbial dynamics in a drinking water distribution system using the culture-free, user-friendly, MYcrobiota platform

    Article • Scientific Reports, October 2018, Springer Science + Business Media

    J HAYS

  16. Detection of Bacterial DNA in Septic Arthritis Samples Using the MYcrobiota Platform

    Article • JCR Journal of Clinical Rheumatology, September 2018, Wolters Kluwer Health

    J HAYS

  17. Unexpected mechanisms of resistance in Dutch Pseudomonas aeruginosa isolates collected during 14 years of surveillance

    Article • International Journal of Antimicrobial Agents, September 2018, Elsevier

    J HAYS

  18. Challenges in identifying antibiotic resistance targets for point-of-care diagnostics in general practice

    Article • Future Microbiology, August 2018, Future Medicine

    J HAYS

  19. Observational multi-centre, prospective study to characterize novel pathogen-and host-related factors in hospitalized patients with lower respiratory tract infections and/or sepsis - the “TAILORED-Treatment” study

    Article • BMC Infectious Diseases, August 2018, Springer Science + Business Media

    J HAYS

  20. Anthrax protective antigen is a calcium-dependent serine protease

    Article • Virulence, July 2018, Taylor & Francis

    J HAYS

  21. Development and evaluation of a culture-free microbiota profiling platform (MYcrobiota) for clinical diagnostics

    Article • European Journal of Clinical Microbiology & Infectious Diseases, March 2018, Springer Science + Business Media

    J HAYS

  22. Galaxy mothur Toolset (GmT): a user-friendly application for 16S rRNA gene sequencing analysis using mothur

    Article • GigaScience, February 2018, Oxford University Press (OUP)

    J HAYS

  23. Characterization of the nasopharyngeal and middle ear microbiota in gastroesophageal reflux-prone versus gastroesophageal reflux non-prone children

    Article • European Journal of Clinical Microbiology & Infectious Diseases, February 2018, Springer Science + Business Media

    J HAYS

  24. Investigations into the killing activity of an antimicrobial peptide active against extensively antibiotic-resistant K. pneumon iae and P. aeruginosa

    Article • Biochimica et Biophysica Acta (BBA) - Biomembranes, October 2017, Elsevier

    J HAYS

  25. Routine molecular point-of-care testing for respiratory viruses in adults presenting to hospital with acute respiratory illness

    Article • Annals of Research Hospitals, July 2017, AME Publishing Company

    J HAYS

  26. Rise of Clostridium difficile infections

    Article • Reviews in Medical Microbiology, June 2017, Wolters Kluwer Health

    J HAYS

  27. Why is scientific research on ‘data-poor’ microorganisms being ignored?

    Article • Future Microbiology, May 2017, Future Medicine

    J HAYS

  28. Novel micelle PCR-based method for accurate, sensitive and quantitative microbiota profiling

    Article • Scientific Reports, April 2017, Nature

    J HAYS

  29. Pre-implementation guidelines for infectious disease point-of-care testing in medical institutions

    Article • Future Microbiology, January 2017, Future Medicine

    J HAYS

  30. Evaluation of the characteristics of leucyl-tRNA synthetase (LeuRS) inhibitor AN3365 in combination with different antibiotic classes

    Article • European Journal of Clinical Microbiology & Infectious Diseases, August 2016, Springer Science + Business Media

    J HAYS

  31. ‘Out-of-the-box’ thinking to help stop the spread of antibiotic resistance

    Article • Future Microbiology, August 2016, Future Medicine

    J HAYS

  32. Detection of Healthcare-Related Extended-Spectrum Beta-Lactamase-Producing Escherichia coli Transmission Events Using Combined Genetic and Phenotypic Epidemiology

    Article • PLoS ONE, July 2016, PLOS

    J HAYS

  33. Comment - Problems with interpretation of microbiota sequencing results

    Article • Clinical Microbiology and Infection, July 2016, Elsevier

    J HAYS

  34. Current problems associated with the microbiological point-of-care testing of respiratory tract infections in primary care

    Article • Future Microbiology, May 2016, Future Medicine

    J HAYS

  35. Detection of amino acid substitutions in the GyrA protein of fluoroquinolone-resistant typhoidal Salmonella isolates using high-resolution mass spectrometry

    Article • International Journal of Antimicrobial Agents, May 2016, Elsevier

    J HAYS

  36. FIVE-YEAR OUTCOMES AFTER LONG-TERM OXANDROLONE ADMINISTRATION IN SEVERELY BURNED CHILDREN

    Article • Shock, April 2016, Wolters Kluwer Health

    J HAYS

  37. A Polymorphism inleuSConfers Reduced Susceptibility to GSK2251052 in a Clinical Isolate of Staphylococcus aureus

    Article • Antimicrobial Agents and Chemotherapy, March 2016, ASM Journals

    J HAYS

  38. Antimicrobial resistance trends in blood culture positive Salmonella Paratyphi A isolates from Pondicherry, India

    Article • Indian Journal of Medical Microbiology, January 2016, Medknow

    J HAYS

  39. Micelle PCR reduces chimera formation in 16S rRNA profiling of complex microbial DNA mixtures

    Article • Scientific Reports, September 2015, Nature

    J HAYS

  40. Moraxella catarrhalis: A mini review

    Article • Journal of Pediatric Infectious Diseases, July 2015, IOS Press

    J HAYS

  41. A multifaceted ‘omics’ approach for addressing the challenge of antimicrobial resistance

    Article • Future Microbiology, March 2015, Future Medicine

    J HAYS, PhD, Microbiology Edward R.B. Moore

  42. Plasmid-Mediated AmpC: Prevalence in Community-Acquired Isolates in Amsterdam, the Netherlands, and Risk Factors for Carriage

    Article • PLoS ONE, January 2015, PLOS

    J HAYS

  43. Moraxella catarrhalis

    Article • January 2015, Elsevier

    J HAYS

  44. Whole-genome mapping for high-resolution genotyping of Pseudomonas aeruginosa

    Article • Journal of Microbiological Methods, November 2014, Elsevier

    J HAYS

  45. Detection and Occurrence of Plasmid-Mediated AmpC in Highly Resistant Gram-Negative Rods

    Article • PLoS ONE, March 2014, PLOS

    J HAYS

  46. Bacterial proteases: targets for diagnostics and therapy

    Article • European Journal of Clinical Microbiology & Infectious Diseases, February 2014, Springer Science + Business Media

    J HAYS

  47. Evaluation of a FRET-Peptide Substrate to Predict Virulence in Pseudomonas aeruginosa

    Article • PLoS ONE, November 2013, PLOS

    J HAYS

  48. Evaluation of a D-amino-acid-containing fluorescence resonance energy transfer peptide library for profiling prokaryotic proteases

    Article • Analytical Biochemistry, October 2013, Elsevier

    J HAYS

  49. Perceptions of point-of-care infectious disease testing among European medical personnel, point-of-care test kit manufacturers, and the general public

    Article • Patient Preference and Adherence, June 2013, Taylor & Francis

    J HAYS

  50. Comprehensive Antigen Screening Identifies Moraxella catarrhalis Proteins That Induce Protection in a Mouse Pulmonary Clearance Model

    Article • PLoS ONE, May 2013, PLOS

    J HAYS

  51. Differential Virulence Gene Expression of Group A Streptococcus Serotype M3 in Response to Co-Culture with Moraxella catarrhalis

    Article • PLoS ONE, April 2013, PLOS

    Dr Anthony R Flores, J HAYS

  52. The Papain Inhibitor (SPI) of Streptomyces mobaraensis Inhibits Bacterial Cysteine Proteases and Is an Antagonist of Bacterial Growth

    Article • Antimicrobial Agents and Chemotherapy, April 2013, ASM Journals

    J HAYS, Felicitas Pfeifer

  53. Microbial profiling does not differentiate between childhood recurrent acute otitis media and chronic otitis media with effusion

    Article • International Journal of Pediatric Otorhinolaryngology, April 2013, Elsevier

    Dr Jacques F Meis, J HAYS

  54. Genome Analysis of Moraxella catarrhalis Strain RH4, a Human Respiratory Tract Pathogen

    Article • Journal of Bacteriology, December 2012, ASM Journals

    J HAYS

  55. Inflammation in the Middle Ear of Children With Recurrent or Chronic Otitis Media Is Associated With Bacterial Load

    Article • The Pediatric Infectious Disease Journal, November 2012, Wolters Kluwer Health

    J HAYS

  56. New type F lineage-related Tn1546 and a vanA/vanB type vancomycin resistant Enterococcus faecium isolated from patients in Dammam, Saudi Arabia during 2006–2007 – ERRATUM

    Article • Epidemiology and Infection, September 2012, Cambridge University Press

    J HAYS

  57. New type F lineage-related Tn1546 and a vanA/vanB type vancomycin-resistant Enterococcus faecium isolated from patients in Dammam, Saudi Arabia during 2006–2007

    Article • Epidemiology and Infection, July 2012, Cambridge University Press

    J HAYS

  58. Comparative Analysis of the Humoral Immune Response to Moraxella catarrhalis and Streptococcus pneumoniae Surface Antigens in Children Suffering from Recurrent Acute Otitis Media and Chronic Otitis Media with Effusion

    Article • Clinical and Vaccine Immunology, April 2012, ASM Journals

    J HAYS

  59. Emergence of multidrug-resistant NDM-1-producing Gram-negative bacteria in Bangladesh

    Article • European Journal of Clinical Microbiology & Infectious Diseases, March 2012, Springer Science + Business Media

    J HAYS

  60. The Role of New Technologies in Medical Microbiological Research and Diagnosis

    Article • March 2012, Bentham Science Publishers

    J HAYS

  61. Campylobacterbacteremia: A rare and under-reported event?

    Article • European Journal of Microbiology and Immunology, March 2012, Akademiai Kiado

    J HAYS

  62. Antimicrobial resistance trends in blood culture positive Salmonella Typhi isolates from Pondicherry, India, 2005–2009

    Article • Clinical Microbiology and Infection, March 2012, Elsevier

    J HAYS

  63. Highly Specific Protease-Based Approach for Detection of Porphyromonas gingivalis in Diagnosis of Periodontitis

    Article • Journal of Clinical Microbiology, November 2011, ASM Journals

    J HAYS

  64. Temporal development of the humoral immune response to surface antigens of Moraxella catarrhalis in young infants

    Article • Vaccine, August 2011, Elsevier

    J HAYS

  65. Mobile Genetic Elements inMoraxella catarrhalis

    Article • Mobile Genetic Elements, July 2011, Taylor & Francis

    J HAYS

  66. Moraxella

    Article • April 2011, Taylor & Francis

    J HAYS

  67. Comparative analysis and supragenome modeling of twelve Moraxella catarrhalis clinical isolates

    Article • BMC Genomics, January 2011, Springer Science + Business Media

    J HAYS

  68. Molecular characterization of antimicrobial resistance in non-typhoidal salmonellae associated with systemic manifestations from India

    Article • Journal of Medical Microbiology, December 2010, Society for General Microbiology

    J HAYS

  69. Colonization of healthy children by Moraxella catarrhalis is characterized by genotype heterogeneity, virulence gene diversity and co-colonization with Haemophilus influenzae

    Article • Microbiology, September 2010, Society for General Microbiology

    J HAYS

  70. Determinants of Moraxella catarrhalis colonization in healthy Dutch children during the first 14 months of life

    Article • Clinical Microbiology and Infection, July 2010, Elsevier

    J HAYS

  71. High prevalence of ST-78 infection-associated vancomycin-resistant Enterococcus faecium from hospitals in Asunción, Paraguay

    Article • Clinical Microbiology and Infection, June 2010, Elsevier

    J HAYS

  72. Genome Analysis of Moraxella catarrhalis Strain RH4, a Human Respiratory Tract Pathogen

    Article • Journal of Bacteriology, May 2010, ASM Journals

    J HAYS

  73. Important methodological considerations with respect to differentiation of CTX-M-15 and CTX-M-28 extended-spectrum beta-lactamases

    Article • Indian Journal of Medical Microbiology, January 2010, Medknow

    J HAYS

  74. Molecular Aspects of Moraxella catarrhalis Pathogenesis

    Article • Microbiology and Molecular Biology Reviews, December 2009, ASM Journals

    J HAYS

  75. bro β-lactamase and antibiotic resistances in a global cross-sectional study of Moraxella catarrhalis from children and adults

    Article • Journal of Antimicrobial Chemotherapy, November 2009, Oxford University Press (OUP)

    J HAYS

  76. The evaluation of putative endogenous control housekeeping genes for real-time polymerase chain reaction expression studies in Moraxella catarrhalis

    Article • Diagnostic Microbiology and Infectious Disease, November 2009, Elsevier

    J HAYS

  77. Dominance of CTX-M-2 and CTX-M-56 among extended-spectrum  -lactamases produced by Klebsiella pneumoniae and Escherichia coli isolated in hospitals in Paraguay

    Article • Journal of Antimicrobial Chemotherapy, October 2009, Oxford University Press (OUP)

    J HAYS

  78. Molecular Aspects of Moraxella catarrhalis Pathogenesis

    Article • Microbiology and Molecular Biology Reviews, September 2009, ASM Journals

    J HAYS

  79. The Application of Randomly Amplified DNA Analysis in the Molecular Epidemiology of Microorganisms

    Article • January 2009, Springer Science + Business Media

    J HAYS

  80. Age-related genotypic and phenotypic differences in Moraxella catarrhalis isolates from children and adults presenting with respiratory disease in 2001-2002

    Article • Microbiology, April 2008, Society for General Microbiology

    J HAYS

  81. Analysis of VanA vancomycin-resistant Enterococcus faecium isolates from Saudi Arabian hospitals reveals the presence of clonal cluster 17 and two new Tn1546 lineage types

    Article • Journal of Antimicrobial Chemotherapy, January 2008, Oxford University Press (OUP)

    J HAYS

  82. Principles and Technical Aspects of PCR Amplification

    Article • January 2008, Springer Science + Business Media

    J HAYS

  83. High-throughput amplification fragment length polymorphism (htAFLP) analysis identifies genetic lineage markers but not complement phenotype-specific markers in Moraxella catarrhalis

    Article • Clinical Microbiology and Infection, January 2007, Elsevier

    J HAYS

  84. Unveiling electrotransformation ofMoraxella catarrhalisas a process of natural transformation

    Article • FEMS Microbiology Letters, September 2006, Oxford University Press (OUP)

    J HAYS

  85. Identification and Characterization of a Novel Outer Membrane Protein (OMP J) of Moraxella catarrhalis That Exists in Two Major Forms

    Article • Journal of Bacteriology, December 2005, ASM Journals

    J HAYS

  86. Moraxella catarrhalisis only a weak activator of the mannose-binding lectin (MBL) pathway of complement activation

    Article • FEMS Microbiology Letters, August 2005, Oxford University Press (OUP)

    J HAYS

  87. A novel plasmid (pEMCJH03) isolated from moraxella catarrhalis possibly useful as a cloning and expression vector within this species

    Article • Plasmid, May 2005, Elsevier

    J HAYS

  88. Pneumococcal vaccination does not affect the genetic diversity of Moraxella catarrhalis isolates in children

    Article • European Journal of Clinical Microbiology & Infectious Diseases, September 2004, Springer Science + Business Media

    J HAYS

  89. Changes in genetic types and population dynamics of Moraxella catarrhalis in hospitalized children are not associated with an exacerbation of existing disease

    Article • Journal of Medical Microbiology, September 2003, Society for General Microbiology

    J HAYS

  90. Total genome polymorphism and low frequency of intra-genomic variation in the uspA1 and uspA2 genes of Moraxella catarrhalis in otitis prone and non-prone children up to 2 years of age

    Article • Vaccine, March 2003, Elsevier

    J HAYS

  91. A Nucleic Acid Sequence–Based Amplification Method To Detect Salmonella enterica Serotype Enteritidis Strain PT4 in Liquid Whole Egg

    Article • Journal of Food Protection, July 2002, International Association for Food Protection

    J HAYS

  92. Diagnosis of Influenza in the Community

    Article • Archives of Internal Medicine, September 2001, American Medical Association (AMA)

    J HAYS

  93. Corrigendum

    Article • Letters in Applied Microbiology, August 2000, Wiley

    J HAYS

  94. An RNA transcription-based amplification technique (NASBA) for the detection of viable Salmonella enterica

    Article • Letters in Applied Microbiology, January 2000, Wiley

    J HAYS

  95. PCR sequencing of the spike genes of geographically and chronologically distinct human coronaviruses 229E

    Article • Journal of Virological Methods, November 1998, Elsevier

    J HAYS

  96. The Genus Moraxella

    Article • Springer Science + Business Media

    J HAYS